According to Acorda Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -84.50%. At the end of 2021 the company had an Operating Margin of -84.51%.
Year | Operating Margin | Change |
---|---|---|
2021 | -84.51% | 20.06% |
2020 | -70.39% | -50.62% |
2019 | -142.53% | -3390.19% |
2018 | 4.33% | -110.12% |
2017 | -42.82% | 426.35% |
2016 | -8.13% | -306.91% |
2015 | 3.93% | -43.65% |
2014 | 6.98% | -18.68% |
2013 | 8.58% | 8.11% |
2012 | 7.94% | -27.57% |
2011 | 10.96% | -348.25% |
2010 | -4.41% | -97.03% |
2009 | -148.62% | -3.21% |
2008 | -153.55% | 53.7% |
2007 | -99.90% | 16.44% |
2006 | -85.80% | -87.17% |
2005 | -668.73% | -92.84% |
2004 | -9,336.26% | 27.91% |
2003 | -7,298.95% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Sarepta Therapeutics
SRPT | -88.19% | 4.37% | ๐บ๐ธ USA |
Repligen
RGEN | 27.34% | -132.36% | ๐บ๐ธ USA |
Affimed
AFMD | -210.66% | 149.30% | ๐ฉ๐ช Germany |
BioMarin Pharmaceutical BMRN | 4.83% | -105.72% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.